GenBody COVID-19 Ag Antigen Test Detection kit

The GenBody COVID-19 Ag Antigen Test

is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid antigen from SARS-CoV-2 in nasal swab specimens from individuals who are suspected of being infected with SARS-CoV-2 by their healthcare provider within the first 6 days of onset of symptoms.

FDA EUA

Yes!

Results

15 minutes

Type

Anterior (lower) nasal

Application

Point of care (POC)

Detection

 Provides direct detection of SARS-CoV-2 antigens from nasal swabs

Tests per Kit

25

Sensitivity

92.31%

Specificity

99.04%

Availability

Immediate – 2 weeks

Easy to Use

GenBody COVID-19 Ag test allows for near patient testing without the need of instrumentation or special equipment

FDA EUA

Authorization Letter

Fact Sheet

For Patients

Packaging

Brochure

Fact Sheet

For Healthcare Providers

Brochure

Nasal Swab

Instructions

for Use

FDA Disclaimer

This product has not been FDA cleared or approved, but has been authorized by FDA under an EUA for use by authorized laboratories; this product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

NEED ORDER AND PRODUCT INFORMATION?

We are here to help! Talk to one of our specialists.